Symptomtext
Soreness, redness and swelling at the shot site; Soreness, redness and swelling at the shot site; Soreness, redness and swelling at the shot site; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 59-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 0029N3 and expiration date; not reported), via an unspecified route of administration, administered in Arm Left on 03Mar2021 16:00 (Age at vaccination: 59 Years), as a SINGLE DOSE for covid-19 immunization. The patient's medical history included type 2 diabetes mellitus, hypertension, blood cholesterol increased and depression. The patient previously took jardiance and experienced hypersensitivity, simvastatin and experienced hypersensitivity, victoza and experienced hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04Mar2021, the patient experienced soreness, redness and swelling at the shot site. Patient did not received treatment for adverse events. No covid tested post vaccination. The outcome of all the events was not recovered. No follow-up attempts are needed. No further information is expected.